| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J2350 |
Injection, ocrelizumab, 1 mg |
1,001 |
910 |
$20.10M |
| J2323 |
Injection, natalizumab, 1 mg |
2,940 |
2,809 |
$13.60M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
11,083 |
6,380 |
$6.59M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
33,625 |
32,505 |
$2.14M |
| J0586 |
Injection, abobotulinumtoxina, 5 units |
1,388 |
1,165 |
$1.15M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
10,652 |
10,602 |
$949K |
| 95819 |
|
6,335 |
6,106 |
$877K |
| 99222 |
Initial hospital care, per day, moderate complexity |
8,646 |
8,415 |
$634K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
5,482 |
5,465 |
$622K |
| 95816 |
|
2,730 |
2,721 |
$555K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
13,155 |
6,020 |
$539K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,954 |
11,767 |
$537K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
3,120 |
3,100 |
$528K |
| 99215 |
Prolong outpt/office vis |
5,118 |
5,017 |
$448K |
| 99205 |
Prolong outpt/office vis |
3,827 |
3,797 |
$427K |
| 64615 |
|
5,026 |
5,013 |
$356K |
| 99223 |
Prolong inpt eval add15 m |
3,248 |
3,195 |
$342K |
| 95886 |
|
3,405 |
3,256 |
$303K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,729 |
3,484 |
$246K |
| 72141 |
|
1,765 |
1,763 |
$171K |
| J3032 |
Injection, eptinezumab-jjmr, 1 mg |
51 |
51 |
$165K |
| 95911 |
|
1,230 |
1,199 |
$151K |
| 72156 |
|
799 |
794 |
$133K |
| 99233 |
Prolong inpt eval add15 m |
2,228 |
1,323 |
$125K |
| 64405 |
|
2,201 |
2,136 |
$121K |
| 64642 |
|
2,179 |
2,161 |
$115K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
934 |
928 |
$98K |
| 62323 |
|
732 |
720 |
$96K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,076 |
2,074 |
$69K |
| 64643 |
|
1,802 |
1,794 |
$67K |
| 95913 |
|
402 |
385 |
$65K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
3,470 |
3,346 |
$43K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,512 |
2,069 |
$31K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,121 |
1,627 |
$27K |
| 70544 |
|
280 |
279 |
$27K |
| 96415 |
|
1,178 |
1,077 |
$26K |
| 92250 |
|
942 |
938 |
$18K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
247 |
247 |
$16K |
| 95953 |
|
61 |
24 |
$14K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,143 |
631 |
$12K |
| 92133 |
|
529 |
527 |
$11K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
299 |
218 |
$8K |
| 95874 |
|
353 |
350 |
$8K |
| 95910 |
|
78 |
78 |
$8K |
| 72146 |
|
80 |
80 |
$8K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
294 |
285 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
211 |
207 |
$7K |
| 20552 |
|
254 |
245 |
$5K |
| 62321 |
|
38 |
38 |
$5K |
| 95909 |
|
63 |
63 |
$5K |
| 64400 |
|
50 |
48 |
$5K |
| 72157 |
|
25 |
25 |
$5K |
| 81025 |
|
930 |
908 |
$4K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
325 |
235 |
$4K |
| 99221 |
|
58 |
58 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,776 |
1,489 |
$1K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
215 |
122 |
$1K |
| 62270 |
|
13 |
13 |
$957.78 |
| 64616 |
|
13 |
13 |
$892.54 |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13 |
13 |
$841.17 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
843 |
811 |
$740.61 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,342 |
768 |
$693.95 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
354 |
327 |
$458.57 |
| 92134 |
|
185 |
184 |
$233.81 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12 |
12 |
$24.16 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
13 |
13 |
$0.00 |